hstc810
mAbexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 18, 2022 (NCT05231746)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068611 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07306624 | Phase 2 | Jan 10, 2026 | STCube, Inc. |
| NCT06873763 | Phase 1/Phase 2 (Phase 2) | Jun 9, 2025 | STCube, Inc. |
| NCT06016270 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2023 | STCube, Inc. |
| NCT05990543 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2023 | Korea University |
| NCT05231746 | Phase 1 | Apr 18, 2022 | STCube, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| STCube, Inc. | For profit | 4 | 4 | 2 | 2022 |
| Korea University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1